Aigen Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,546
Closed -$107K 856
2023
Q2
$107K Sell
12,546
-10,421
-45% -$86.9K 0.02% 670
2023
Q1
$210K Buy
+22,967
New +$294K 0.03% 513
2021
Q4
Sell
-4,548
Closed -$288K 1051
2021
Q3
$288K Buy
+4,548
New +$346K 0.06% 351

Other funds holding CDNA

Aigen Investment Management's CDNA Position: Q3 2023 in Review

Aigen Investment Management sold out of CareDx (CDNA) in Q3 2023, closing a stake of 12,546 shares — an estimated $107K sold.

Aigen Investment Management first reported a position in CDNA in Q3 2021 and held it in 3 quarters. The position peaked at $288K in Q3 2021. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.

  • Aigen Investment Management reported no remaining CareDx position as of Q3 2023 after selling out during the quarter.
  • Aigen Investment Management sold 12,546 CareDx shares in Q3 2023, an estimated $107K.
  • Aigen Investment Management first reported a position in CareDx in Q3 2021 and held it in 3 quarters.
  • Aigen Investment Management's CareDx position peaked at $288K in Q3 2021.
  • 150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.

Based on Aigen Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.